| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.76 | 0.002 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |